Gilead CEO John C. Martin - CEO pay report
John C. Martin - Gilead
Total Compensation: $10.8 million
Details: Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in "other" compensation. Most of Martin's slary came from stock and option awards valued at about $10.1 million. Overall, Martin's compensation fell 6.8 percent from 2006.
Gilead News:
FDA approves Letairis
Gilead touts Phase III Hep B results
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
